Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
13.64
+0.21 (1.53%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Teva Pharmaceutical Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$24.00
Upside
+76.02%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $23 → $20 | Strong Buy | Maintains | $23 → $20 | +46.68% | Mar 6, 2025 |
| UBS | UBS | Strong Buy Maintains $30 → $27 | Strong Buy | Maintains | $30 → $27 | +98.02% | Jan 30, 2025 |
| Barclays | Barclays | Buy Maintains $28 → $26 | Buy | Maintains | $28 → $26 | +90.69% | Jan 30, 2025 |
| UBS | UBS | Strong Buy Maintains $28 → $30 | Strong Buy | Maintains | $28 → $30 | +120.02% | Jan 23, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $23 → $30 | Buy | Maintains | $23 → $30 | +120.02% | Jan 17, 2025 |
| Barclays | Barclays | Buy Maintains $25 → $28 | Buy | Maintains | $25 → $28 | +105.35% | Dec 18, 2024 |
| Barclays | Barclays | Buy Maintains $22 → $25 | Buy | Maintains | $22 → $25 | +83.35% | Oct 23, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $16 → $18 | Hold | Maintains | $16 → $18 | +32.01% | Oct 21, 2024 |
| UBS | UBS | Strong Buy Maintains $24 → $26 | Strong Buy | Maintains | $24 → $26 | +90.69% | Sep 3, 2024 |
| Barclays | Barclays | Buy Maintains $21 → $22 | Buy | Maintains | $21 → $22 | +61.35% | Aug 1, 2024 |
| UBS | UBS | Strong Buy Maintains $22 → $24 | Strong Buy | Maintains | $22 → $24 | +76.02% | Jul 10, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $19 → $23 | Strong Buy | Maintains | $19 → $23 | +68.68% | Jun 27, 2024 |
| Barclays | Barclays | Buy Maintains $20 → $21 | Buy | Maintains | $20 → $21 | +54.02% | Jun 5, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $18 → $21 | Strong Buy | Maintains | $18 → $21 | +54.02% | May 30, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $19 → $20 | Buy | Reiterates | $19 → $20 | +46.68% | May 13, 2024 |
| Barclays | Barclays | Buy Maintains $17 → $20 | Buy | Maintains | $17 → $20 | +46.68% | May 9, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.